baber/WOPTO huggingface dataset:
Patent JP-2000512731-A (JP)
IPC: F16C13/02
Filed: 1998-04-14
Abstract: A support device for a rotary drum having at least one roller capable of cooperating with the drum. At least two bearings permit the rotation of the roller about its axis of rotation. The support device has a chassis into which the bearings are secured. The chassis is mounted for pivoting about a pivotal axis substantially perpendicular to the plane passing through the axis of rotation of the roller and perpendicular to a block onto which the support device is placed. The device also includes a connector which is flexible in a given direction and rigid in the directions orthogonal to the direction of flexibility. The connector maintains the bearings on the block while permitting free pivotal movement of the chassis in such a way to permit alignment of the roller on the drum in the event of pivoting.
Patent JP-2002510260-A (JP)
Title: モータ駆動装置
IPC: H02K11/33
Filed: 1998-04-02
Abstract: (57)【要約】
本発明は、特にマグネットバルブを制御するために使用される電気要素用であって、一側部に設けられたマグネットバルブとカバー（５）用のハウジング本体（２）を有する自動車のブレーキシステム用のモータ駆動装置に関する。本発明の特徴は、前記要素を同一の接触力でハウジング本体（２）に取着することが出来る取着手段（１５）が、カバー（５）とエンジンのケーシング（９）との間に設けられていることである。電子装置（３）とエンジンケーシング（９）とは、このように上述の特徴によって、同質的にシールできる。取着手段（１５）の配置によって提供される更なる利点は、材料を節約することができ、また、組み立てが簡単になることである。
Patent MX-196732-A (MX)
Inventor: WITTWER FRITZ
IPC: A23J3/00
Filed: 1983-03-25
Abstract: An apparatus and method to produce capsules of a moldable hydrophilic polymer composition, preferably gelatin, using a combination of an injection molding device with a microprocessor (28) to precisely control the conditions of time, temperature, pressure and water content of the hydrophilic polymer composition, in a cyclic molding process, are disclosed. The injection molding device comprises a hopper unit (5) for feeding gelatin to an injection unit (1) from which plasticised gelatin is injected into a molding unit (2).
Patent NZ-186372-A (NZ)
Title: Document protection systems
Inventor: MCELLIGOTT MJ
IPC: G03G15/22
Filed: 1978-02-01
Abstract: PROTECTION SYSTEM FOR DOCUMENTS of the Invention A system to protect documents such as negotiable instruments, title instruments and identification documents. from illegal copying by color copiers and alteration such as amount or signature particularly computer printout documents comprising preprinting a "VOID" pattern over the amount and/or signature area of the document in solvent insoluble or color change ink.  The VOID is printed with a camouflage pattern overcoating.  The camouflage pattern overcoating may be a pattern or solid coating.  It may be a coating on the undersurface of the Mylar* film overlay of the "VOID.  Thereafter the disclosure contemplates adhering the Mylar*film to the document to be protected over the amount and/or signature area with cold pressure. Color copying by machine is prevented by the use of colors in the inks which are below the critical density of the copier, so as to verify the authenticity of a document and prevent fraudulent use of a copy. *Trademark
Patent NZ-202721-A (NZ)
Title: Diflunisal derivatives and pharmaceutical compositions
Inventor: DORN C P
IPC: C07C68/06
Filed: 1982-12-06
Abstract: 1-(alkoxy or aroxy)carbonyloxyalkyl esters of structural formula (I):   <CHEM>  wherein:  R is (a) lower alkyl;  (b) lower cycloalkyl;  (c) unsubstituted or substituted aryl; or  (d) aralkyl;  R<1> is (a) hydrogen;  (b) lower alkyl;  (c) lower cycloalkyl; or  (d) aryl;  R<2> is (a) hydrogen;  (b) lower alkanoyl;  (c) lower alkoxycarbonyl;  R<3> is (a) hydrogen; or  (b) lower alkyl; and  X is halo are disclosed. Those compounds are stable in aqueous medium and non-irritant to mucous embranes of mouth, throat, and stomach. Accordingly, they are useful Prodrugs of the analgesic and anti-inflammatory drug diflunisal.
Patent NZ-210914-A (NZ)
Title: 4,6,6a,7,8,12b-hexahydroindolo(4,3-ab)phenanthridine,derivatives thereof and pharmaceutical compositions
Inventor: HAGENBACH A
IPC: C07D457/14
Filed: 1985-01-23
Abstract: 4,6,6a,7,8,12b-hexahydro-indolo[4,3-ab]phenanthridines are useful as dopaminergic and analgesic agents.
Patent NZ-216659-A (NZ)
Title: Process for the preparation of poly(diorganosiloxanes) having ether end groups
Inventor: WEBER W
IPC: C08G77/08
Filed: 1986-06-25
Abstract: A process for the preparation of triorganooxysilyl- or diorganooxyorganosilyl-terminated poly(diorganosiloxanes) or formulations containing such siloxanes comprising reacting  alpha , omega -dihydroxypoly(diorganosiloxanes) with tetraorganyloxysilanes or triorganyloxyorganosilanes in the presence of an ammonium carbamate catalyst of the formula I    <IMAGE>  (I)  wherein, R represents a hydrocarbon radical with 1-20 C atoms or an H atom, and where identical or different R radicals are in the molecule. The products produced by this process can be employed in the preparation of one-component silicone paste which harden into elastomers in the presence of moisture.
Patent NZ-229563-A (NZ)
Title: A pulsed liquid metering device
Inventor: SMITH TIMOTHY J N
IPC: A61M5/14
Filed: 1989-06-14
Abstract: A pulsed liquid injection device for injection of predetermined dosage volumes of medication at predetermined intervals of time over an extended period is described. A relatively large supply of medication is maintained in a bag under pressure, and metered portions thereof are released at time intervals by an electronically controlled metering device. The metering device includes a simple valve arrangement (37) containing three flexible resilient elements (36, 41, 45) arranged and controlled in such a way as to provide positive shut off of medication supply in the event of a malfunction, either electrical or mechanical.
Patent NZ-235428-A (NZ)
Title: Process for making phospholipoprotein containing foodstuff by enzyme treatment
Inventor: CARRELL REBECCA SUSAN
IPC: A23L9/10
Filed: 1990-09-24
Abstract: A process for the manufacture of a lysophospholipoprotein (LPLP)-comprising foodstuff comprises incorporating dried LPLP or dried LPLP-comprising material, preferably having a moisture content of at most 10 wt%, at a level of 0.1-90 wt.% therein. Use of dried LPLP as a texture-modifying agent, a glossing agent, a freeze-thaw stabilizing agent, a heat-stabilizing agent and a syneresis-inhibiting agent, as well as the foodstuff per se has also been claimed.
Patent NZ-239812-A (NZ)
Title: An interdental brush has a foamed end over an annular boss
Inventor: KAMINSKI JOHN A
IPC: A61C17/00
Filed: 1991-09-16
Abstract: An interdental brush is provided with brush members formed of an open cell foam material adhered circumferentially around an elongate plastic stem. The stem extends beyond the brush by a distance sufficient for the stem to form a brush handle. The brush can be molded or laminated onto the stem.
Patent NZ-243507-A (NZ)
Title: Process for preventing laddering in a stocking-like filter of a fruit press
Inventor: HARTMANN EDUARD
IPC: B30B9/26
Filed: 1992-07-10
Abstract: PCT No. PCT/CH92/00169 Sec. 371 Date Apr. 27, 1993 Sec. 102(e) Date Apr. 27, 1993 PCT Filed Aug. 26, 1992 PCT Pub. No. WO93/04849 PCT Pub. Date Mar. 18, 1993.At both ends of a filter cover (6), respectively in the fastening area of the filter cover on draining element (1), bondings or settings (12, 14, 15, 16, 17, 18, 19, 10, 21) of stitches (10) are applied, which are interrupted in one or more of first rows of stitches (11) and are offset in one or more rows of stitches at the end of the fastening area in the peripheral direction. In a modification, setting (22) of stitches (10) at the end of the fastening area is placed uninterrupted in the peripheral direction. These settings partially or completely allow runs in the fastening area of a filter cover (6), so that, on the one hand, an enlargement of filter cover (6) is made possible for the assembly, and, on the other hand, the formation of runs outside the fastening area is prevented.
Patent NZ-288026-A (NZ)
Title: A method for producing influenza hemagglutinin multivalent vaccines
Inventor: SMITH GALE EUGENE
IPC: C12N15/62
Filed: 1995-05-26
Abstract: A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a multivalent, preferably trivalent, influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential. The recombinant hemagglutinin antigens are full length, uncleaved (HAO), glycoproteins produced from baculovirus expression vectors in cultured insect cells and purified under non-denaturing conditions. In the preferred embodiment, the cloned HA genes are then modified by deletion of the natural hydrophobic signal peptide sequences and replacing them with a new baculovirus chitinase signal peptide. A general approach for the efficient extraction and purification of recombinant HA protein produced in insect cells is also disclosed for the purification of rHA proteins from A sub-types and B type influenza viruses.
Patent NZ-289089-A (NZ)
Title: Recombinant xylanase stable at 80 degrees c and ph above and its use in pulp production
Inventor: GRONBERG VIDAR
IPC: C12S3/08
Filed: 1995-06-14
Abstract: The invention provides thermostable xylanases.
Patent NZ-297444-A (NZ)
Title: Synergistic fungicidal composition comprising at least one 4-phenoxyquinoline, 2-phenylaminopyrimidine, glyoxylic acid, triazolylmethyloxirane or cyanopyrrole derivative
Inventor: WAGNER OLIVER
IPC: A01N43/36
Filed: 1995-12-05
Abstract: Disclosed is a fungicidal mixture that contains in synergistically effective quantity: a) a compound of formula (I), its N-oxide or one of its salts, wherein the radicals R1, R2, R3, R4 are hydrogen, hydroxy, nitro, halogen, alkyl, alkyl halide, alkoxy, alkoxy halide, alkylthio, alkylthio halide, and R5, R6, R7 are hydrogen, hydroxy, cyano, nitro, halogen, alkyl, alkyl halide, alkoxy, alkoxy halide, alkylthio, alkylthio halide, alkyl hydroxy, acyl, aryl, aryloxy; b) a compound of formula (II), wherein the radical R8 is phenyl which can carry one to three of the following groups: cyano, halogen, alkyl, alkyl halide and alkoxy, or is pyrimidyl which can carry an alkyl group and/or a phenoxy group, A is oxygen or oxymethylene (-OCH2-); X is CH or N; Y is oxygen or NR, R being hydrogen, alkyl or alkoxy, or c) a pyrimidine derivative of formula (III) or one of its salts, wherein the radical R9 is methyl, propin-1-yl or cyclopropyl, or d) (2<u>RS</u>, 3<u>SR</u>)-1-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl-methyl)-1<u>H</u>-1,2,4-triazole (IV), or e) a compound of formula (V), wherein R10 is fluorine or chlorine, R11 is trifluoromethyl or chlorine or R10 and R11 together are an -OCF2O- group.
Patent NZ-320963-A (NZ)
Title: Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
Inventor: FISHER MATTHEW J
IPC: A61K31/537
Filed: 1996-09-27
Abstract: This invention relates to certain spirocyclic compounds substituted with both basic and acidic functionality, as shown by formula (I):wherein Q, L, Ai, Bj, R0, R3, R10, m, n, p and q are as defined in the disclosure, which are useful in inhibiting of platelet aggregation.
Patent NZ-322227-A (NZ)
Title: Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
Inventor: MACDONALD JAMES
IPC: A61K31/5513
Filed: 1996-11-06
Abstract: There are provided compounds of formula (I), wherein X, R1, R2, R3, R4 and R5 are as defined in the specification and optical isomers and racemates thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy.
Patent NZ-330507-A (NZ)
Title: Device for sustained release of a composition to a ruminant animal comprises spring, piston and thimble
Inventor: LOWE LIONEL BARRY
IPC: A61M21/00
Filed: 1992-04-03
Abstract: A sustained release capsule adapted to be inserted into the rumen of a ruminant animal and means for retention of the capsule in the rumen. <??>A sustained release capsule (8) adapted to be inserted into the rumen of a ruminant animal through its oesophagus and retained within the rumen over a prolonged period to continuously deliver a biologically active composition (32) carried in the capsule (8), comprising an elongated tubular body (10) comprising a tube (16) and an end cap (12) secured to one end thereof for substantially enclosing the biologically active composition (32), the other end of the capsule (8) being a delivery end (18), the body (10) having an opening (20) at the delivery end (18) of the capsule (8) for delivery of the composition (32) to the rumen, and a plurality of retention arms (44) attached to or formed integrally with the cap (12), the arms (44) being adapted to extend outwardly from the cap (12) for retaining the capsule (8) in the rumen, the arms (44) being resilient to enable them to bend from their outwardly extending positions toward the body (10) so that they lie alongside the body (10) allowing the capsule (8) to be inserted through the animal's oesophagus, the resilient arms (44) normally extending from the body (10) at an angle between 75 DEG  and 90 DEG  with respect to the axis of the tubular body (10), and for each arm (44) said cap (12) has an external curved surface (26) disposed with respect to the arm (44) so that when the arm (44) is bent toward the body (10), the arm (44) contacts the curved surface (26) and the curved surface (26) controls the bending of the arm (44) so that the arm (44) does not bend abruptly, said arms (44) being adapted to return to their outwardly extending positions when the capsule (8) reaches the rumen, characterised in that said cap (12) is secured to said one end by means of at least two circumferential beads (30) having at least one sealing ring (31) located therebetween. <IMAGE>
Patent NZ-332717-A (NZ)
Title: Absorbent pants comprise pants layer and barrier layer wherein barrier layer is arranged at the same level as the leg and waist openings
Inventor: GUSTAFSSON ANDERS
IPC: A61F5/44
Filed: 1996-02-01
Abstract: Absorbent pants have a waist opening and two leg openings, a pants layer 5 which during use is intended to face the body and an outer barrier layer 6.  An absorption material is arranged between pants layer 5 and outer barrier layer 6.  Pants layer 5 has a surface which is greater than outer barrier layer 6.  Pants layer 5 is joined in parts with itself or comprises means to enable it to be joined in parts with itself so that it, during use of the pants, alone constitutes the waist opening and leg openings of the pants.  The load bearing parts of the pants and all of the parts in contact with the body of the user in this way are formed from pants layer 5 alone.  Pants layer 5 has at least one opening 34, 35 for the passage of urine and or faeces whereby outer barrier layer 6 covers the opening/s.  Pants layer 5 is hydrophobic and outer barrier layer 6 is continuously connected in connection areas to the pants layer around the opening/s.
Patent NZ-334207-A (NZ)
Title: Portable gas burner for fireplaces and camp fires with three dimensional contoured ceramic fibre top
Inventor: SHIMEK RONALD J
IPC: F24C3/00
Filed: 1999-02-16
Abstract: Hollow ceramic fibre top 12 is contoured in three dimensions and forms hollow manifold 13 which receives a gas mixture.  The gas burner assembly is portable.
Patent NZ-335418-A (NZ)
Title: Polyolefins and derivatives useful as lubricants or fuel additives
Inventor: RATH HANS PETER
IPC: C10M133/52
Filed: 1997-11-03
Abstract: A polyolefin obtained by catalytic dimerisation of at least monosaturated  olefin oligomers, these being homo- or co-oligomers of C3-6-olefins; selected from propene, 1-butene, isobutene, 1-pentene, 2-methylbutene, 1-hexene, 2-methylpentene, 3-methylpentene or 4-methylpentene. The polyolefin having a number mean molecular weight in the range of 400 to 1,500 dalton and a dispersibility of Mw/Mn < 1.2 and being monoethylenically unsaturated. The functionalised polyolefin is described as Formula (I), wherein; R is a polyolefin radical; i is an integer from 1-4 and when i is 1, X is a functional group of Formula (II). k and l, independently of one another, are each 0 or 1, R' is hydrogen, alkyl, hydroxylalkyl, aminoalkyl, cycloalkyl, aryl, aralkyl or -Y-Z, -Y- is a group represent Formula (III), wherein Alk and Alk' are identical or different and are each C2-4alkylene, p is an integer from 0-10, and R'' is hydrogen, alkyl or aryl, and -Z- is selected amongst Formula (IV), wherein R1 and R2 is independently selected from hydrogen, alkyl, cycloalkyl, hydroxyalkyl, aryl or aralkyl; A is C3-5-alkylene; A' is C2-4-alkylene or C2-4-alkenylene; m is 1 or 2, L is hydrogen, alkyl, aryl, aralkyl, hetaryl or hetaralkyl; and Z' is selected amongst Formula (V), where R3-R12 is independently selected from hydrogen, alkyl, aryl, hetaryl, aralkyl or hetaralkyl, q is 1-50 and Alk' is C2-4-alkylene. The derivatives of these polyolefins which can be obtained by functionalizing at least a double link of the polyolefin. The polyolefins and/or functionalisation products serve as additives for fuels or lubricants.
Patent NZ-500445-A (NZ)
Title: Implantable drug delivery device, uses piezo devices to produce peristaltic pumping action
Inventor: JELLIE HUGH PHILIP
IPC: A61M31/00
Filed: 1996-03-25
Abstract: An implantable drug delivery device for implantation into an animal includes reservoirs 13 for holding the substances to be delivered.  These reservoirs are connected to flexible delivery line 16.  Fluid is moved along line 16 towards outlet 17 by piezo-electric devices 15 compressing the line in sequence to cause a peristaltic pumping action.  The piezo-electric devices may be controlled by a programmable microprocessor 18, and are powered by battery 18.
Patent NZ-500669-A (NZ)
Title: Electric convection heater constructed from extruded aluminium parts
Inventor: HUNG CHIN-PING
IPC: F24D15/02
Filed: 1999-10-28
Abstract: The electric heating elements or plates of an electric heater are arranged within a receiving chamber 10 on either side of which are arrayed a plurality of heat sink members 20.  The heat sink members and the receiving chamber are formed of aluminum extrusions.  The controller 40 mounted on the heater controls power supply to the heating elements. Heat energy from the elements is absorbed by the extruded aluminum plates of the receiving chamber and conducted to the heat sink extrusions whereby heat is exchanged by convection with cool air.
Patent NZ-500860-A (NZ)
Title: Keyboard overlay indicating alternative key functions, edges of overlay fit under sides of keys at edges of keyboard
Inventor: MOSTERT VICTORIA ELIZABETH
IPC: G06F3/02
Filed: 2000-03-21
Abstract: A keyboard overlay consists of a thin resilient member 7.  The overlay has pockets 6 which fit over the individual keys 1.  The overlay is secured in places by lower edges 12 which fit under the keys at the edges of the keyboard.  The overlay  has markings that indicate key functions different from those printed on the keys.
Patent NZ-506853-A (NZ)
Title: C11 oxymyl and hydroxylamino prostaglandins (PGF) analogs useful as medicaments
Inventor: DELONG MITCHELL ANTHONY
IPC: A61K31/215
Filed: 1999-03-22
Abstract: A compound having the structure (I), characterized in that; R1 is CO2H, C(O)NHOH, CO2R7, CH2OH, S(O)2R7, C(O)NHR7, C(O)NHS(O)2R7, or tetrazole; R7 is alkyl, heteroalkyl, carbocyclic aliphatic ring, heterocyclic aliphatic ring, aromatic ring, or heteroaromatic ring; W is O, NH, S, S(O),  S(O)2, or (CH2)m; characterized in that m is an integer from 0 to 3; R2 is H and R3 is H or lower alkyl, or R2 and R3 together form a covalent bond; R4 is H, alkyl, heteroalkyl, carbocyclic aliphatic ring, heterocyclic aliphatic ring, aromatic ring, or heteroaromatic ring, provided that when each R5 and R6 is H, R4 is other than methyl; R5 is independently selected from the group consisting of H, CH3, and C2H5; X is NHR8 or OR8, characterized in that each R8 is independently selected from the group consisting of H, acyl, alkyl, heteroalkyl, carbocyclic aliphatic ring, heterocyclic aliphatic ring, aromatic ring, and heteroaromatic ring; R6 is independently selected from the group consisting of H, CH3, C2H5, OR8, and NHR8; Z is H, methyl, carbocyclic ring, heterocyclic ring or aromatic ring; a and b are independently selected from the group consisting of single bond, cis double bond, and trans double bond; p is an integer from 0 to 6; and any optical isomer, diastereomer, enantiomer of the above structure or a pharmaceutically-acceptable salt, or bio-hydrolyzable amide, ester, or imide thereof. The above compound is useful for the treatment of a bone disorder or glaucoma in a human or any other mammal.
Patent NZ-507436-A (NZ)
Title: Use of NMDA antagonists for treatment of irritable bowel syndrome (IBS) and compounds with NMDA receptor antagonistic properties
Inventor: ASGHAR AZIZ
IPC: A61K31/4965
Filed: 1999-04-28
Abstract: Described is the use of pharmaceutical compounds having NMDA antagonist activity for treating certain conditions  in the    gastrointestinal   tract,    such    as    functional gastrointestinal  disorders,  and  in  particular  irritable bowel  syndrome  (IBS).  Also described  are  pharmaceutical compositions to be used in the treatment of IBS and products comprising such compositions and a pharmaceutical acceptable carrier. Figure 5 shows the results for memantine and Figure 6  shows the  corresponding  results  with  2-amidino-6-  (2-amino-2- phenyl)-ethylpyridine. Results    and   conclusions:    Intra-arterially   injected memantine  reduced, in a dose-dependent fashion, the  pelvic nerve  activity elicited by distension of the colon  (80  mm Hg), as can be seen from Figure 5. The observations hereby provided are consistent with a model in   which  the  non-competitive  NMDA-antagonist  memantine reduces  the  pelvic nerve activity elicited  by  colorectal distension  by a peripheral mechanism of action.   The  data shown  in  Figure  6  was obtained when the  experiment  was repeated with 2amidino-6- (2-amino-2-phenyl)-ethylpyridine.
Patent NZ-516231-A (NZ)
Title: Large round baler with baling chamber having lower belt run with movable roller, moving from upper central position to lower rearward position causing lower run to be substantially planar
Inventor: LUCAND PHILLIPE
IPC: A01F15/07
Filed: 2001-12-18
Abstract: A large round baler includes an expansible baling chamber having an inlet at a forward location thereof and defined in part by a lower run of a flexible, endless component arrangement of an upper conveyor, and by an upper run of a flexible, endless component arrangement of a bottom conveyor. In each of two embodiments, the bottom conveyor includes a moveable roller which operates to selectively deflect the upper run of the bottom conveyor so that it cooperates with a lower run of the upper conveyor so as define a baling chamber having a cross section conducive to starting a bale core at the beginning of the baling process and moveable to a discharge position for allowing a completed bale to roll onto the ground. In the second embodiment, the upper conveyor also includes a moveable roller operates to yieldably resist expansion of the lower run of the upper conveyor.
Patent NZ-518276-A (NZ)
Title: Sizing catheter for measuring cardiovascular structures
Inventor: AFREMOV MICHAEL R
IPC: A61B5/107
Filed: 2000-11-28
Abstract: A sizing catheter (10) and method of measuring a preselected internal opening within a patient to provide a rapid and precise determination of first and second stretched diameters of the preselected internal opening. The sizing catheter (10) includes a dilation balloon (26) constructed of a thin expandable plastic, which is inflatable and is utilized to determine a size of the preselected opening. The dilation balloon (26) is affixed to the tubular shaft (12) proximate the distal end (16) of the tubular shaft (12). The dilation balloon (26) is inflated to an inflation threshold wherein the dilation balloon (26) deforms about the preselected opening and the size of the dilation balloon (26) adjacent the preselected opening approximates the first stretched diameter of the preselected opening. The sizing catheter (10) and method may be utilized to determine an appropriate sized device to be positioned within the preselected opening.